Price T Rowe Associates Inc 10x Genomics, Inc. Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 271,078 shares of TXG stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271,078
Previous 251,264 7.89%
Holding current value
$3.51 Million
Previous $2.2 Million 43.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$7.14 - $11.73 $141,471 - $232,418
19,814 Added 7.89%
271,078 $3.14 Million
Q1 2025

May 14, 2025
SELL
$8.73 - $16.31 $13.4 Million - $25 Million
-1,530,004 Reduced 85.89%
251,264 $2.2 Million
Q4 2024

Feb 14, 2025
SELL
$13.18 - $21.31 $9.68 Million - $15.7 Million
-734,635 Reduced 29.2%
1,781,268 $25.6 Million
Q3 2024

Nov 14, 2024
SELL
$15.71 - $23.49 $5.62 Million - $8.41 Million
-358,049 Reduced 12.46%
2,515,903 $56.8 Million
Q2 2024

Aug 14, 2024
SELL
$19.45 - $37.37 $15.2 Million - $29.3 Million
-783,275 Reduced 21.42%
2,873,952 $55.9 Million
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $20 Million - $30 Million
553,053 Added 17.82%
3,657,227 $137 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $14.3 Million - $24 Million
416,723 Added 15.51%
3,104,174 $174 Million
Q3 2023

Nov 14, 2023
BUY
$40.86 - $62.98 $1.23 Million - $1.9 Million
30,127 Added 1.13%
2,687,451 $111 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $12.4 Million - $14.3 Million
243,364 Added 10.08%
2,657,324 $148 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $14.2 Million - $22.4 Million
401,785 Added 19.97%
2,413,960 $135 Million
Q4 2022

Feb 14, 2023
SELL
$24.4 - $41.3 $8.22 Million - $13.9 Million
-337,054 Reduced 14.35%
2,012,175 $73.3 Million
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $28.8 Million - $53.1 Million
1,010,643 Added 75.5%
2,349,229 $66.9 Million
Q2 2022

Aug 15, 2022
BUY
$36.95 - $82.41 $6.94 Million - $15.5 Million
187,833 Added 16.32%
1,338,586 $60.6 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $4.1 Million - $10.7 Million
73,541 Added 6.83%
1,150,753 $87.5 Million
Q4 2021

Feb 14, 2022
BUY
$135.05 - $182.59 $14.2 Million - $19.2 Million
105,195 Added 10.82%
1,077,212 $160 Million
Q3 2021

Nov 15, 2021
SELL
$145.58 - $192.14 $13.5 Million - $17.8 Million
-92,621 Reduced 8.7%
972,017 $142 Million
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $31.3 Million - $47.3 Million
233,535 Added 28.1%
1,064,638 $208 Million
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $3.53 Million - $4.96 Million
-25,183 Reduced 2.94%
831,103 $150 Million
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $108 Million - $140 Million
856,286 New
856,286 $121 Million

Others Institutions Holding TXG

# of Institutions
330
Shares Held
117M
Call Options Held
442K
Put Options Held
149K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.23B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email